Advanced Biomed (ADVB) Return on Capital Employed (2025 - 2026)

Advanced Biomed's (ADVB) quarterly Return on Capital Employed came in at 49.66% in Q1 2026, up 17460.0% year-on-year from N/an in Q1 2025, and down 7.63% quarter-over-quarter from 53.76% in Q4 2025.

Advanced Biomed (ADVB) Return on Capital Employed (2025 - 2026) Analysis & Trends

Advanced Biomed has disclosed Return on Capital Employed across 2 years of filings, most recently posting 49.66% for Q1 2026.

  • Return on Capital Employed for Q1 2026 came in at 49.66%, up 17460.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 49.66% (up 17460.0% YoY), and the FY2025 annual result was 297.97%, changed N/A from the prior year.
  • Return on Capital Employed came in at 49.66% for Q1 2026 at Advanced Biomed, down from 53.76% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 53.76% in Q4 2025 to a low of 389.74% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Waters 29,902.70 Bn 29,902.24 Bn 1.11 Bn 4.82%
2 Thermo Fisher Scientific 175.99 Bn 172.74 Bn 7.74 Bn 8.12%
3 Danaher 129.87 Bn 124.18 Bn 3.59 Bn 6.26%
4 Idexx Laboratories 44.75 Bn 44.55 Bn 722.74 Mn 67.98%
5 Agilent Technologies 37.52 Bn 35.72 Bn 990.00 Mn 14.57%
6 Iqvia Holdings 30.91 Bn 28.94 Bn 1.36 Bn 10.24%
7 Natera 30.21 Bn 29.11 Bn 696.04 Mn -3.63%
8 Illumina 24.19 Bn 23.04 Bn 721.00 Mn 16.90%
9 Mettler Toledo International 23.12 Bn 23.06 Bn 555.82 Mn 45.73%
10 Advanced Biomed - - - 49.66%

Historic Data

Download Data
DateValue
Mar 31, 2026 49.66%
Dec 31, 2025 53.76%
Sep 30, 2025 -52.78%
Jun 30, 2025 -389.74%
Mar 31, 2025 -124.95%